Retrospective study of Pembrolizumab in heavily pretreated metastatic castrate-resistant prostate cancer (mCRPC) patients
Latest Information Update: 11 Mar 2019
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Bone cancer; Prostate cancer
- Focus Therapeutic Use
Most Recent Events
- 11 Mar 2019 New trial record
- 16 Feb 2019 Results presented at the 2019 Genitourinary Cancers Symposium